OP030: Identification of disease-relevant bacterial signatures in gnotobiotic IL-10 deficient mice using fecal samples from IBD patients undergoing hematopoietic stem cell transplantationECCO'17 Barcelona 2017
1
OP031: Long-term safety and tolerability of oral tofacitinib in patients with Crohn’s Disease: Results from a phase 2 open-label 48-week extension studyECCO'17 Barcelona 2017
1
OP032: Efficacy and safety of oral tofacitinib as maintenance therapy in patients with Moderate to Severe Ulcerative Colitis: Results from a phase 3 randomised controlled trialECCO'17 Barcelona 2017
1
OP034: Efficacy and safety of abrilumab in subjects with Moderate to Severe Ulcerative Colitis: Results of a phase 2b, randomised, double-blind, multiple-dose, placebo-controlled studyECCO'17 Barcelona 2017
1
OP035: Efficacy and safety of abrilumab (AMG 181/MEDI 7183) therapy for Moderate to Severe Crohn’s DiseaseECCO'17 Barcelona 2017
1
OP036: Short duration, low intensity pooled faecal microbiota transplantation induces remission in patients with mild- moderately active Ulcerative Colitis: A randomised controlled trialECCO'17 Barcelona 2017
1
OP037: Infants born to mothers with Inflammatory Bowel Disease exhibit distinct microbiome features that persist up to 3 months of lifeECCO'17 Barcelona 2017
1
OP038: Impact of ileocecal resection in Crohn’s Disease patients on mucosal microbiotaECCO'17 Barcelona 2017
1
Outcomes from the 2015-2016 Fellowships: Hypoxia, antophagy and inflammasomeECCO'17 Barcelona 2017
1
Outcomes from the 2015-2016 Fellowships: Post-genomic application in general, and the establishment of computational approaches relevant to translational medicineECCO'17 Barcelona 2017
1
Perform endoscopy and IBD incl. chromo-endoscopy, balloon dilatation15th IBD Intensive Advanced Course 2017
1
Recreating the intestine ex vivo - Where are we on the way to the artificial gut (organoids, etc.)5th SciCom Workshop: Methodology on Research 2017
1